SMTL ID : 8tzg.1

Structure of C-terminal LRRK2 bound to MLi-2 (I2020T mutant)

Coordinates
PDB Format
Method
ELECTRON MICROSCOPY
Oligo State
monomer
Ligands
1 x A1N: (2~{R},6~{S})-2,6-dimethyl-4-[6-[5-(1-methylcyclopropyl)oxy-1~{H}-indazol-3-yl]pyrimidin-4-yl]morpholine(Non-covalent)
1 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
1 x MG: MAGNESIUM ION(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Sanz Murillo, M. et al., Inhibition of Parkinson's disease-related LRRK2 by type I and type II kinase inhibitors: Activity and structures. Sci Adv (2023)
Release Date
2023-12-06
Peptides
Leucine-rich repeat serine/threonine-protein kinase 2: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Leucine-rich repeat serine/threonine-protein kinase 2